MBHB partner Paul Tully, Ph.D. is a featured presenter at the American Conference Institute’s Paragraph IV Disputes Master Symposium, set for Oct. 3-4, 2103 in Chicago.
Details for Dr. Tully’s presentation are as follows:
Friday, Oct. 4 – 3:30-4:45 p.m.
Protonix – Case Study of An At Risk Launch: Pros and Cons Analysis of Launching At Risk and Survey of New Developments in Seeking Injunctive Relief and Damages
This past June, Pfizer and Teva finally reached an agreement in the Protonix case wherein Teva agreed to pay Pfizer $2.15 Billion relative to an at-risk launch. Against the backdrop of this case, this panel will explore at-risk launches, brand and generic strategies for seeking and opposing injunctive relief and new considerations in damages estimation and awards.
About American Conference Institute
A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world. Staffed by industry specialists, lawyers and other professionals, American Conference Institute operates as a think tank, monitoring trends and developments in all major industry sectors, the law, and public policy, with a view to providing information on the leading edge.
View complete details including registration at http://americanconference.com/PIVdisputeschicago